Relation between riboflavin, flavin mononucleotide and flavin adenine dinucleotide concentrations in plasma and red cells in patients with critical illness

Clinica Chimica Acta

Volumn 411, Issue 21-22, 2010, Pages 1750-1755

  Vasilaki, Aikaterini T ^a,b   McMillan, Donald C ^a   Kinsella, John ^a   Duncan, Andrew ^b   O'Reilly, Denis St J ^b   Talwar, Dinesh ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NHS Greater Glasgow and Clyde Clinical Biochemistry Service   (United Kingdom)

Author keywords

Critical illness; Flavin adenine dinucleotide; Flavin mononucleotide; Plasma; Red cell; Riboflavin

Indexed keywords

FLAVINE ADENINE NUCLEOTIDE; FLAVINE MONONUCLEOTIDE; RIBOFLAVIN;

ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; ERYTHROCYTE LEVEL; FEMALE; FOLLOW UP; HEALTH STATUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; RELIABILITY; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CRITICAL ILLNESS; ERYTHROCYTES; FEMALE; FLAVIN MONONUCLEOTIDE; FLAVIN-ADENINE DINUCLEOTIDE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RIBOFLAVIN; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77956475326     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.07.024     Document Type: Article

References (21)

1. Grimble R.F. Effects of antioxidative vitamins on immune function with clinical applications. Int J Vitam Nutr Res 1997, 67:312-320.
2. Kodama K., Suzuki M., Toyosawa T., Araki S. Inhibitory mechanisms of highly purified vitamin B2 on the productions of proinflammatory cytokine and NO in endotoxin-induced shock in mice. Life Sci 2005, 78:134-139.
3. Shenkin S.D., Cruickshank A.M., Shenkin A. Subclinical riboflavin deficiency is associated with outcome of seriously ill patients. Clinical Nutrition 1989, 8:269-271.
4. McCormick D.B., Innis W.S.A., Merrill A.H., Bowers-Komro D.M., Oka M., Chastain J.L. An update on flavin metabolism in rats and humans. Flavin and flavoproteins 1988, 459-471. Walter de Gruyter, New York. D.E. Edmondson, D.B. McCormick (Eds.).
5. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics 2006, 1075-1164. Chapter 30, Elsevier Saunders, St. Louis, MO. Fourth Edition. C.A. Burtis, E.R. Ashwood, D.E. Bruns (Eds.).
6. Bates C.J. Vitamin analysis. Ann Clin Biochem 1997, 34:599-626.
7. Hustad S., McKinley M.C., McNulty H., Schneede J., Strain J.J., Scott J.M., Ueland P.M. Riboflavin, flavin mononucleotide, and flavine adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supplementation. Clin Chem 2002, 48:1571-1577.
8. Massey V. The chemical and biological versatility of riboflavin. Biochem Soc Trans. 2000, 28:283-296.
9. Stripp B. Intestinal absorption of riboflavin by man. Acta Pharmacol Toxicol (Copenh). 1965, 22:353-362.
10. Gray A., McMillan D.C., Wilson C., Williamson C., O'Reilly D.S., Talwar D. The relationship between plasma and red cell concentrations of vitamins thiamine diphosphate, flavin adenine dinucleotide and pyridoxal 5-phosphate following elective knee arthroplasty. Clin Nutr 2004, 23:1080-1083.
11. Quasim T., McMillan D.C., Talwar D., Vasilaki A., O'Reilly D.S., Kinsella J. The relationship between plasma and red cell B-vitamin concentrations in critically-ill patients. Clin Nutr 2005, 24:956-960.
12. Louw J.A., Werbeck A., Louw M.E.J., Kotze T.J.V.W., Cooper R., Labadarios D. Blood vitamin concentrations during the acute-phase response. Crit Care Med 1992, 20:934-941.
13. Innis W.S., McCormick D.B., Merrill A.H. Variations in riboflavin binding by human plasma: identification of immunoglobulins as the major proteins responsible. Biochem Med 1986, 34:151-165.
14. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., Schein R.M.H., Sibbald J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655.
15. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
16. Speek A.J., van Schaik F., Schrijver J., Schreurs W.H. Determination of the B2 vitamin flavin-adenine dinucleotide in whole blood by high-performance liquid chromatography with fluorometric detection. J Chromatogr 1982, 228:311-316.
17. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999, 340:448-454.
18. Aw T.Y., Jones D.P., McCormick D.B. Uptake of riboflavin by isolated rat liver cells. J Nutr 1983, 113:1249-1254.
19. McCormick D.B., Zhang Z. Cellular assimilation of water-soluble vitamins in the mammal: riboflavin, B6, biotin and C. Proc Soc Exp Biol Med 1993, 202:265-270.
20. Vasilaki A.T., McMillan D.C., Kinsella J., Duncan A., O'Reilly D.S., Talwar D. Relation between pyridoxal and pyridoxal phosphate concentrations in plasma, red cells and white cells in patients with critical illness. Am J Clin Nutr 2008, 88:140-146.
21. Talwar D.K., Azharuddin M.K., Williamson C., Teoh Y.P., McMillan D.C., O'Reilly D.S. Biological variation of vitamins in blood of healthy individuals. Clin Chem 2005, 51:2145-2150.